6HL-21046-68868
4 vaccinations
4 coded responses
40 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 452 / OH
- Registered
- 2021-04-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-30
Dose 1 — Pfizer-BioNTech
-
2021-04-20
Dose 2 — Pfizer-BioNTech
-
2021-04-21
Registered in v-safe
-
2021-04-21
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness, Syncope — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Dizziness/faintingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-04-23
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-04-29
- 2021-05-06
- 2021-05-13
- 2021-05-18
- 2021-05-25
- 2021-07-20
- 2021-10-19
-
2021-11-17
Dose 3 — Pfizer-BioNTech
- 2021-11-17
-
2021-11-18
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea · Be unable to work or attend schoolAdult check-in
- 2021-11-19
- 2021-11-20
- 2021-11-22
- 2021-11-23
- 2021-11-24
- 2021-12-01
- 2021-12-08
- 2021-12-15
- 2021-12-24
- 2021-12-29
- 2022-02-16
- 2022-05-18
-
2022-11-29
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-11-30
Survey response — days 1–6 daily, dose 4MedDRA: Injection site bruising — Feeling: Fair · Site: Pain, Redness · Chills, Headache, Fatigue or tirednessFree text: Bruise at injection siteMedDRA releases: 2024-11 · check-in free text available
- 2022-12-01
- 2022-12-02
- 2022-12-03
- 2022-12-04
- 2022-12-06
-
2022-12-13
Survey response — day 14, dose 4MedDRA: Headache, Oropharyngeal pain, Rhinorrhoea — Feeling: FairFree text: Sore throat, runny nose, headacheMedDRA releases: 2024-11 · check-in free text available
- 2022-12-20
- 2022-12-27
-
2023-01-03
Survey response — day 35, dose 4MedDRA: Cough, Rhinorrhoea, Sneezing — Feeling: FairMedDRA releases: 2024-11
- 2023-01-10
- 2023-02-28
- 2023-06-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-30 | Pfizer-BioNTech | |
| 2 | 2021-04-20 | Pfizer-BioNTech | |
| 3 | 2021-11-17 | Pfizer-BioNTech | No |
| 4 | 2022-11-29 | Pfizer-BioNTech | Flu |
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Dizziness/fainting
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Bruise at injection site
Release 12 — day 14, dose 4
Symptoms: Sore throat, runny nose, headache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Injection site bruising | · | · | ✓ |
| SRO | Syncope | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release